Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Nealon

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Infection|September 20, 2024
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trialJacob Christensen, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
The Journal of Infectious Diseases|August 12, 2025
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
Diabetes, Obesity & Metabolism|April 8, 2024
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Daniel Modin, et al.
Journal of the American College of Cardiology|September 1, 2024
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: A Secondary Analysis of DANFLU-1Katja Vu Bartholdy, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
NEJM Evidence|February 6, 2024
A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 14, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 10, 2026
Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting reportLaurence de Moerlooze, Alexander Allen, Ilaria Bartalesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2024
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trialNiklas Dyrby Johansen, Daniel Modin, Kristoffer Grundtvig Skaarup, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 15, 2026
Positive Predictive Value of Respiratory Infection Diagnoses in The Danish National Patient Registry: a Post-hoc Validation Analysis of the DANFLU-1 TrialJacob Christensen, Niklas Dyrby Johansen, Katrine Feldballe Bernholm, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 29, 2026
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trialKatrine Feldballe Bernholm, Niklas Dyrby Johansen, Caroline Espersen, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Infection|September 20, 2024
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trialJacob Christensen, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
The Journal of Infectious Diseases|August 12, 2025
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
Diabetes, Obesity & Metabolism|April 8, 2024
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Daniel Modin, et al.
Journal of the American College of Cardiology|September 1, 2024
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: A Secondary Analysis of DANFLU-1Katja Vu Bartholdy, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
NEJM Evidence|February 6, 2024
A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 14, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 10, 2026
Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence - a meeting reportLaurence de Moerlooze, Alexander Allen, Ilaria Bartalesi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2024
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trialNiklas Dyrby Johansen, Daniel Modin, Kristoffer Grundtvig Skaarup, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 15, 2026
Positive Predictive Value of Respiratory Infection Diagnoses in The Danish National Patient Registry: a Post-hoc Validation Analysis of the DANFLU-1 TrialJacob Christensen, Niklas Dyrby Johansen, Katrine Feldballe Bernholm, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 29, 2026
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trialKatrine Feldballe Bernholm, Niklas Dyrby Johansen, Caroline Espersen, et al.
Pageof 8